Two new antivirals for HIV may be approved soon

Two new antivirals for HIV may be approved soon...Viracept (nelfinavir) and Rescriptor (delavirdine).

Viracept will be the fourth protease inhibitor on the market.

It has just been released through an expanded access program...for patients with advanced AIDS when the other protease inhibitors don't work or cause intolerable side effects.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote